The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Lund Stem Cell Center scientists awarded a 5-year grant from Vinnova

Professors Anna Falk and Malin Parmar
Professors Anna Falk (left) and Malin Parmar (right) will use the funding from Vinnova to establish a collaborative innovative environment for precision medicine with their project IndiCell. (Photo Anna Falk: private, photo Malin Parmar: Kennet Ruona)

Vinnova is Sweden's innovation agency with the mission to build Sweden’s innovation capacity. Earlier this year they announced a call for projects aiming to establish “Innovative environments for precision medicine” and last week they announced that the Lund-based project IndiCell is one of the funded projects.

IndiCell is a collaborative project designed to connect academia, hospitals and industry to generate a workflow from academic stem cell research into the clinic. The project has a strong focus on individualized stem cell therapy with Parkinson’s disease and Macular Degeneration as exemplars. IndiCell was funded with 40 million SEK over 5 years and is coordinated by Anna Falk (LU), with Malin Parmar (LU) and Fredrik Lanner (KI) as co-coordinators and includes partners from Lund university (LU), Karolinska Institutet (KI), Royal Institute of Technology (KTH), Skåne University Hospital, Karolinska Hospital, Biolamina, Acousort AB and MAGic BioProcessing.

Read more about the funded innovative environments at Vinnova’s hompage.